Association of Kynurenine Aminotransferase II Gene C401T Polymorphism with Immune Response in Patients with Meningitis

Overview

Journal BMC Med Genet

Publisher Biomed Central

Specialty Genetics

Date 2011 Apr 9

PMID 21473761

Citations 13

Authors

Fladjule Rejane Soares de Souza

Fabricia Lima Fontes

Thayse Azevedo da Silva

Leonam Gomes Coutinho

Stephen L Leib

Lucymara Fassarella Agnez-Lima

Affiliations

Soon will be listed here.

Abstract

Background: The kynurenine (KYN) pathway has been shown to be altered in several diseases which compromise the central nervous system (CNS) including infectious diseases such as bacterial meningitis (BM). The aim of this study was to assess single nucleotide polymorphisms (SNPs) in four genes of KYN pathway in patients with meningitis and their correlation with markers of immune response in BM.

Methods: One hundred and one individuals were enrolled in this study to investigate SNPs in the following genes: indoleamine-2,3-dioxygenase (IDO1 gene), kynureninase (KYNU gene), kynurenine aminotransferase I (CCBL1 gene), and kynurenine aminotransferase II (AADAT gene). SNP analyses were performed by primer-introduced restriction analysis-PCR (PIRA-PCR) followed by RFLP. Cytokines were measured using multiplex bead assay while immunoglobulins (IG) by immunodiffusion plates and NF-kappaB and c-Jun by dot blot assay.

Results: The variant allele of SNP AADAT+401C/T showed prevalent frequency in patients with BM. A significant decrease (p < 0.05) in TNF-α, IL-1β, IL-6, MIP-1αCCL3 and MIP-1β/CCL4 levels was observed in BM patients homozygous (TT) to the SNP AADAT+401C/T. Furthermore, a significant (p < 0.05) decrease in cell count was observed in cerebrospinal fluid (CSF) from patients with TT genotype. In addition, an increase in the IgG level in adults (p < 0.05) was observed. The variant allele for KYNU+715G/A was found with low frequency in the groups, and the SNPs in IDO1+434T/G, KYNU+693G/A, CCBL1+164T/C, and AADAT+650C/T had no frequency in this population.

Conclusions: This study is the first report of an association of SNP AADAT+401C/T with the host immune response to BM, suggesting that this SNP may affect the host ability in recruitment of leukocytes to the infection site. This finding may contribute to identifying potential targets for pharmacological intervention as adjuvant therapy for BM.

Citing Articles

Exploring transcriptomic databases: unraveling circadian gene disruptions in lower grade glioma.

Hou W, Hou W, Zhao X Sci Rep. 2024; 14(1):16960.

PMID: 39043735 PMC: 11266536. DOI: 10.1038/s41598-024-67559-9.

The Genetics of Eczema Herpeticum.

Hodara E, Ong P Clin Rev Allergy Immunol. 2022; 63(3):390-397.

PMID: 36114947 DOI: 10.1007/s12016-022-08953-x.

Relationships of Ischemic Stroke Occurrence and Outcome with Gene Variants Encoding Enzymes of Tryptophan Metabolism.

Boros F, Maszlag-Torok R, Szucs M, Annus A, Klivenyi P, Vecsei L Biomedicines. 2021; 9(10).

PMID: 34680558 PMC: 8533114. DOI: 10.3390/biomedicines9101441.

Variation of Genes Encoding Tryptophan Catabolites Pathway Enzymes in Stroke.

Wigner P, Saluk-Bijak J, Synowiec E, Miller E, Sliwinski T, Cichon N J Clin Med. 2019; 8(12).

PMID: 31817010 PMC: 6947300. DOI: 10.3390/jcm8122133.

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway.

Boros F, Vecsei L Front Immunol. 2019; 10:2570.

PMID: 31781097 PMC: 6851023. DOI: 10.3389/fimmu.2019.02570.

References

Kepplinger B, Baran H, Kainz A, Ferraz-Leite H, Newcombe J, Kalina P . Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes. Neurosignals. 2005; 14(3):126-35. DOI: 10.1159/000086295. View

Pfister H, Scheld W . Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol. 1997; 10(3):254-9. DOI: 10.1097/00019052-199706000-00015. View

OConnor J, Andre C, Wang Y, Lawson M, Szegedi S, Lestage J . Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci. 2009; 29(13):4200-9. PMC: 2835569. DOI: 10.1523/JNEUROSCI.5032-08.2009. View

Stone T, Perkins M . Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol. 1981; 72(4):411-2. DOI: 10.1016/0014-2999(81)90587-2. View

Inaba Y, Ishiguro A, Shimbo T . The production of macrophage inflammatory protein-1alpha in the cerebrospinal fluid at the initial stage of meningitis in children. Pediatr Res. 1997; 42(6):788-93. DOI: 10.1203/00006450-199712000-00012. View

Schwarcz R, Rassoulpour A, Wu H, Medoff D, Tamminga C, Roberts R . Increased cortical kynurenate content in schizophrenia. Biol Psychiatry. 2001; 50(7):521-30. DOI: 10.1016/s0006-3223(01)01078-2. View

Leib S, Clements J, Lindberg R, Heimgartner C, Loeffler J, Pfister L . Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 2001; 124(Pt 9):1734-42. DOI: 10.1093/brain/124.9.1734. View

Stone T, Darlington L . Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov. 2002; 1(8):609-20. DOI: 10.1038/nrd870. View

Janoff E, Rubins J . Invasive pneumococcal disease in the immunocompromised host. Microb Drug Resist. 1997; 3(3):215-32. DOI: 10.1089/mdr.1997.3.215. View

10.

Lindell D, Standiford T, Mancuso P, Leshen Z, Huffnagle G . Macrophage inflammatory protein 1alpha/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Infect Immun. 2001; 69(10):6364-9. PMC: 98771. DOI: 10.1128/IAI.69.10.6364-6369.2001. View

11.

Stone T, Mackay G, Forrest C, Clark C, Darlington L . Tryptophan metabolites and brain disorders. Clin Chem Lab Med. 2003; 41(7):852-9. DOI: 10.1515/CCLM.2003.129. View

12.

Nemeth H, Toldi J, Vecsei L . Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res. 2005; 2(3):249-60. DOI: 10.2174/1567202054368326. View

13.

Schwarcz R, Whetsell Jr W, Mangano R . Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 1983; 219(4582):316-8. DOI: 10.1126/science.6849138. View

14.

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

15.

Smirnova I, Mann N, Dols A, Derkx H, Hibberd M, Levin M . Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A. 2003; 100(10):6075-80. PMC: 156328. DOI: 10.1073/pnas.1031605100. View

16.

Vallabhapurapu S, Karin M . Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009; 27:693-733. DOI: 10.1146/annurev.immunol.021908.132641. View

17.

Ogasawara N, Oguro T, Sakabe T, Matsushima M, Takikawa O, Isobe K . Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species. J Cell Biochem. 2009; 108(3):716-25. DOI: 10.1002/jcb.22308. View

18.

Hirst R, Kadioglu A, OCallaghan C, Andrew P . The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol. 2004; 138(2):195-201. PMC: 1809205. DOI: 10.1111/j.1365-2249.2004.02611.x. View

19.

Koedel U, Scheld W, Pfister H . Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002; 2(12):721-36. DOI: 10.1016/s1473-3099(02)00450-4. View

20.

Bellac C, Coimbra R, Christen S, Leib S . Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury. Neurobiol Dis. 2006; 24(2):395-402. DOI: 10.1016/j.nbd.2006.07.014. View